Camlin Fine Sciences Limited — Board Meeting, 08-08-2025: Outcome of Board Meeting

Camlin Fine Sciences has announced a board meeting where the financial results for the quarter and half-year were approved. For the quarter ended June 30, 2025, the company reported consolidated revenue of ₹423.55 Cr. The net loss attributable to owners stood at ₹9.96 Cr, resulting in a basic EPS of ₹(0.53). The board also approved the re-appointment of Mr. Joseph Conrad D’Souza as a Non-Executive Independent Director for a second five-year term, pending shareholder approval. Furthermore, CFO Mr. Santosh Parab has been given interim charge of the Human Resources & Administration Department.